Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix randomized double-blind placebo-controlled phase 3 trial in endometriosis-associated pain
2011-004295-11Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of elagolix in endometriosis (3 arms), sponsored by AbbVie Inc. Primary endpoints: Responder rate for dysmenorrhea at Month 3 and Responder rate for non-menstrual pelvic pain at Month 3. Started Jul 2013; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2011-004295-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004295-11.